Fig. 4 | Scientific Reports

Fig. 4

From: Anti-tumor efficacy and safety of AEV01 in preclinical glioblastoma and hepatocellular carcinoma models

Fig. 4

Effects of AEV01 on expression of CD36 (A) U-87 MG, (B) HepG2, (C) Palmitic acid treated HepG2 cells at low and high doses as individually and in combination with AEV01 and (D) WRL-68 (senescence cells). Patterns of positive and negative staining for CD36 were identified by fluorescent microscopy at 20 × magnification. Quantification was performed using ImageJ software. Data are denoted as Mean ± SD, ***p < 0.001 when compared with the control, n = 3.

Back to article page